FDA Inspection 1178579 — Heartland Center For Reproductive Medicine, PC
The FDA completed an inspection of Heartland Center For Reproductive Medicine, PC on Jul 29, 2022 in Omaha, NE. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 29, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Omaha, NE (United States)